MG
CPHI icon

Marex Group’s China Pharma Holdings CPHI Stock Holding History

Marex Group’s Portfolio CPHI Stock Details CPHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,340
Closed -$3.17K – 707
2024
Q3 		$3.17K Buy
+1,340
New +$2.96K ﹤0.01% 600

Other funds holding CPHI

TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
FCT
First Community Trust Dubuque, Iowa $221M AUM 48.25% 1-Year Est. Return

Marex Group's CPHI Position: Q4 2024 in Review

Marex Group sold out of China Pharma Holdings (CPHI) in Q4 2024, closing a stake of 1,340 shares — an estimated $3.17K sold.

Marex Group first reported a position in CPHI in Q3 2024 and held it in 1 quarter. The position peaked at $3.17K in Q3 2024. 5 funds tracked by Wall St. Rank hold CPHI as of Q4 2024.

  • Marex Group reported no remaining China Pharma Holdings position as of Q4 2024 after selling out during the quarter.
  • Marex Group sold 1,340 China Pharma Holdings shares in Q4 2024, an estimated $3.17K.
  • Marex Group first reported a position in China Pharma Holdings in Q3 2024 and held it in 1 quarter.
  • Marex Group's China Pharma Holdings position peaked at $3.17K in Q3 2024.
  • 5 funds tracked by Wall St. Rank held China Pharma Holdings as of Q4 2024.

Based on Marex Group's 13F filing for Q4 2024, filed 2 Apr 2026.